NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Nexalin Technology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.36+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $49.90M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$43.24 (−94.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Nexalin Technology, Inc. grew revenue 24.2% to $217.16K over the twelve months to Jun 30, 2026.
Revenue
$217.16K
+24.2% vs. a year earlier
Operating income
-$9.13M
TTM Q2 2026
EPS, diluted
-$0.48
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $49.90M
- P/E ratio
- –
- Price to sales
- 229.78
- Price to book
- 32.84
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $217.16K
- Net income
- -$8.99M
- EPS, diluted
- -$0.48
- Book value per share
- $0.07
- Diluted shares
- 21M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$217.16K+24.2% YoY
Gross profit
$187.10K+58.3% YoY
Operating income
-$9.13M
Net income
-$8.99M
EPS, diluted
-$0.48
Reported periodTrailing twelve months